These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 27486148)

  • 21. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
    Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major depressive disorder treatment guidelines in America and Europe.
    Davidson JR
    J Clin Psychiatry; 2010; 71 Suppl E1():e04. PubMed ID: 20371031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods.
    Lam RW; Kennedy SH; Parikh SV; MacQueen GM; Milev RV; Ravindran AV;
    Can J Psychiatry; 2016 Sep; 61(9):506-9. PubMed ID: 27486152
    [No Abstract]   [Full Text] [Related]  

  • 25. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.
    Bauer M; Severus E; Köhler S; Whybrow PC; Angst J; Möller HJ;
    World J Biol Psychiatry; 2015 Feb; 16(2):76-95. PubMed ID: 25677972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines.
    Bauer M; Severus E; Möller HJ; Young AH;
    Int J Psychiatry Clin Pract; 2017 Sep; 21(3):166-176. PubMed ID: 28367707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
    MacQueen G; Santaguida P; Keshavarz H; Jaworska N; Levine M; Beyene J; Raina P
    Can J Psychiatry; 2017 Jan; 62(1):11-23. PubMed ID: 27554483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.
    McIntyre RS; Alsuwaidan M; Goldstein BI; Taylor VH; Schaffer A; Beaulieu S; Kemp DE;
    Ann Clin Psychiatry; 2012 Feb; 24(1):69-81. PubMed ID: 22303523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh SV; MacQueen G; McIntyre RS; Sharma V; Beaulieu S;
    Bipolar Disord; 2006 Dec; 8(6):721-39. PubMed ID: 17156158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder.
    McIntyre RS; Rosenbluth M; Ramasubbu R; Bond DJ; Taylor VH; Beaulieu S; Schaffer A;
    Ann Clin Psychiatry; 2012 May; 24(2):163-9. PubMed ID: 22563572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.
    Han C; Wang SM; Kato M; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2013 Jul; 13(7):851-70. PubMed ID: 23898855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary.
    Malhi GS; Bell E; Singh AB; Bassett D; Berk M; Boyce P; Bryant R; Gitlin M; Hamilton A; Hazell P; Hopwood M; Lyndon B; McIntyre RS; Morris G; Mulder R; Porter R; Yatham LN; Young A; Murray G
    Bipolar Disord; 2020 Dec; 22(8):788-804. PubMed ID: 33320412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.